Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial

LCMC study investigators

Research output: Contribution to journalArticlepeer-review

112 Scopus citations

Fingerprint

Dive into the research topics of 'Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Immunology and Microbiology